Related Experiment Video
Updated: Nov 29, 2025

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
Characterization of MSlys, the endolysin of Streptococcus pneumoniae phage MS1
Maria Daniela Silva1, Hugo Oliveira1, Alberta Faustino2
1CEB - Centre of Biological Engineering, LIBRO - Laboratório de Investigação em Biofilmes Rosário Oliveira, University of Minho, 4710-057 Braga, Portugal.
Abstract:
Despite the use of pneumococcal conjugate vaccines, the number of infections related to Streptococcus pneumoniae continues to be alarming. Herein, we identified, characterized the MSlys endolysin encoded in the phage MS1. We further tested its antimicrobial efficacy against planktonic and biofilm cells, assessing the culturability of cells and biofilm structure by scanning electron microscopy, and confocal laser scanning microscopy. The modular MSlys endolysin consists of an amidase catalytic domain and a choline-binding domain. MSlys is active against isolates of children with otitis media, and conditions close to those found in the middle ear. Treatment with MSlys (2 h, 4 μM) reduced planktonic cultures by 3.5 log10 CFU/mL, and 24- and 48-h-old biofilms by 1.5 and 1.8 log10 CFU/mL, respectively. Imaging of the biofilms showed thinner and damaged structures compared to control samples. The recombinantly expressed MSlys may be a suitable candidate for treating pneumococcal infections, including otitis media.
Insights
A novel bacteriophage endolysin, MSlys, shows significant antimicrobial activity against Streptococcus pneumoniae. This discovery offers a promising new therapeutic candidate for treating persistent pneumococcal infections, including otitis media.
Area of Science:
- Microbiology
- Biotechnology
- Infectious Diseases
Background:
- * *Streptococcus pneumoniae* infections remain a significant global health concern despite widespread vaccination.
- * Novel therapeutic strategies are urgently needed to combat antibiotic-resistant pneumococcal strains.
Purpose of the Study:
- * To identify and characterize the MSlys endolysin from phage MS1 for its potential as an antimicrobial agent.
- * To evaluate the efficacy of MSlys against planktonic and biofilm forms of *Streptococcus pneumoniae*.
Main Methods:
- * Recombinant expression and characterization of the MSlys endolysin.
- * Antimicrobial activity assays against *S. pneumoniae* isolates from otitis media.
- * Scanning electron microscopy and confocal laser scanning microscopy to assess biofilm structure.
Main Results:
- * MSlys demonstrated potent lytic activity against *S. pneumoniae*, including clinical isolates.
- * Treatment with MSlys significantly reduced planktonic bacterial cultures and disrupted 24- and 48-hour-old biofilms.
- * Microscopic analysis revealed thinner and damaged biofilm structures post-MSlys treatment.
Conclusions:
- * The endolysin MSlys exhibits promising antimicrobial properties against *Streptococcus pneumoniae*.
- * MSlys represents a potential therapeutic candidate for treating pneumococcal infections, particularly otitis media.
More Related Videos
09:12Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
09:26Identification of Antibacterial Immunity Proteins in Escherichia coli using MALDI-TOF-TOF-MS/MS and Top-Down Proteomic Analysis
Published on: May 23, 2021
Related Concept Videos
Formation of Lipopolysaccharides
DNA Bacteriophages
Lysogenic Cycle of Bacteriophages
Viral Replication: Lytic Cycle
Viral Replication: Lysogenic Cycle
Lytic Cycle of Bacteriophages